#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marginal zone lymphoma refractory Precursor T-lymphoblastic lymphoma/leukaemia recurrent Kidney transplant rejection Neovascular age-related macular degeneration Juvenile psoriatic arthritis Malignant fibrous histiocytoma Oesophageal squamous cell carcinoma stage III Burkitt's lymphoma refractory Fibrous dysplasia of bone Piriformis syndrome Familial haemophagocytic lymphohistiocytosis Restless legs syndrome Pseudoxanthoma elasticum Stargardt's disease Paraneoplastic neurological syndrome More trials…

    Learn about Rare Diseases

    Synovial sarcoma metastatic – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Diagnostics Hereditary optic atrophy – Life with Disease Stevens-Johnson syndrome IgA nephropathy – Diagnostics Sarcoidosis – Trials in Disease Hairy cell leukaemia recurrent – Diagnostics Short-bowel syndrome – Trials in Disease Alveolar rhabdomyosarcoma Cystic fibrosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    HALOBETASOL PROPIONATE Alnus Glutinosa Pollen Phleum Pratense GSKVX000000039711 Alclometasone Dipropionate Azd7798 AGA2118 Pemetrexed Disodium Amisulpride Io103 Acetate Enmetazobactam Idursulfase Garadacimab Losartan Potassium Testosterone Undecanoate Spartalizumab Gemcitabine Hydrochloride Kpl-404 Resiniferatoxin Carbasalate Calcium More therapies…

    Learn about Your Condition

    Malignant peritoneal neoplasm Mucosal inflammation Skin neoplasm excision Dystonic tremor Cardiac sarcoidosis Mantle cell lymphoma Primary biliary cholangitis Mixed-type liposarcoma Cough Breast cancer stage II Acute promyelocytic leukaemia K-ras gene mutation Cutaneous sarcoidosis Noninfective chorioretinitis Craniocerebral injury More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effects of Pegvisomant and Somatropin on Liver Fat Metabolism in Patients with Acromegaly and Healthy Individuals

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acromegaly
    Investigated Drugs:
    • PEGVISOMANT
    • Somatropin
    Austria

  • Study of Single-Dose Rabies Vaccine (Inactivated Flury LEP Strain) Immunity After Five Years: Testing Booster Response in Previously Vaccinated Adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rabies
    The Netherlands

  • Study on Fecal Microbiota Transfer for Better Diabetes Control in Adults with Type 2 Diabetes After Bariatric Surgery

    Recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    • Placebo
    France

  • Study on How Etrasimod Arginine is Absorbed in Blood and Breast Milk of Healthy Breastfeeding Women with Ulcerative Colitis and Other Inflammatory Disorders

    Recruiting

    1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Etrasimod Arginine
    Belgium

  • Study on Denosumab to Prevent Breast Cancer in Women with BRCA1 Mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Denosumab
    Austria Germany Spain

  • Study on Levosimendan for Improving Survival in Patients with Out-of-Hospital Cardiac Arrest During CPR

    Recruiting

    2 1 1
    Investigated Drugs:
    • Levosimendan
    Sweden
Previous Page
1 … 191 192 193 194 195 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!